Ling Wang


Oppenheimer Initiates Outperform on Geron Corporation; Sees 33% Upside for the Stock

In a research report issued April 20, Oppenheimer analyst Ling Wang initiated coverage on shares of Geron Corporation (NASDAQ:GERN) with an Outperform rating and price …

Rockwell Medical: Oppenheimer Expects Strong Commercial Launch For Triferic Following FDA Approval

In a research report sent to investors today, Oppenheimer analyst Ling Wang reiterated an Outperform rating on Rockwell Medical (NASDAQ:RMTI) with a $26 price …

Oppenheimer’s Ling Wang Expects Rockwell Medical Shares To Have Significant Upside

Oppenheimer analyst Ling Wang initiated Outperform rating on Rockwell Medical (NASDAQ:RMTI) with a $24 price target, which represents a potential upside of 152% …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts